Novel Virtual Screening Approach for the Discovery of Human Tyrosinase Inhibitors

被引:24
作者
Ai, Ni [1 ]
Welsh, William J. [2 ]
Santhanam, Uma [3 ]
Hu, Hong [3 ]
Lyga, John [3 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China
[2] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA
[3] AVON Prod Inc, Global R&D, Suffern, NY USA
关键词
SHAPE SIGNATURES; DRUG DISCOVERY; DESIGN;
D O I
10.1371/journal.pone.0112788
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tyrosinase is the key enzyme involved in the human pigmentation process, as well as the undesired browning of fruits and vegetables. Compounds inhibiting tyrosinase catalytic activity are an important class of cosmetic and dermatological agents which show high potential as depigmentation agents used for skin lightening. The multi-step protocol employed for the identification of novel tyrosinase inhibitors incorporated the Shape Signatures computational algorithm for rapid screening of chemical libraries. This algorithm converts the size and shape of a molecule, as well its surface charge distribution and other bio-relevant properties, into compact histograms (signatures) that lend themselves to rapid comparison between molecules. Shape Signatures excels at scaffold hopping across different chemical families, which enables identification of new actives whose molecular structure is distinct from other known actives. Using this approach, we identified a novel class of depigmentation agents that demonstrated promise for skin lightening product development.
引用
收藏
页数:11
相关论文
共 25 条
[1]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[2]   Shape signatures: New descriptors for predicting cardiotoxicity in silico [J].
Chekmarev, Dmitriy S. ;
Kholodovych, Vladyslav ;
Balakin, Konstantin V. ;
Ivanenkov, Yan ;
Ekins, Sean ;
Welsh, William J. .
CHEMICAL RESEARCH IN TOXICOLOGY, 2008, 21 (06) :1304-1314
[3]   Investigation of potential glycogen synthase kinase 3 inhibitors using pharmacophore mapping and virtual screening [J].
Dessalew, Nigus ;
Bharatam, Prasad V. .
CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 68 (03) :154-165
[4]   Application of Screening Methods, Shape Signatures and Engineered Biosensors in Early Drug Discovery Process [J].
Hartman, Izabela ;
Gillies, Alison R. ;
Arora, Sonia ;
Andaya, Christina ;
Royapet, Nitya ;
Welsh, William J. ;
Wood, David W. ;
Zauhar, Randy J. .
PHARMACEUTICAL RESEARCH, 2009, 26 (10) :2247-2258
[5]   ANALYSIS OF MAMMALIAN PIGMENTATION AT THE MOLECULAR-LEVEL [J].
HEARING, VJ ;
JIMENEZ, M .
PIGMENT CELL RESEARCH, 1989, 2 (02) :75-85
[6]  
Heikamp K, 2012, FUTURE MED CHEM, V4, P1945, DOI [10.4155/fmc.12.126, 10.4155/FMC.12.126]
[7]   Development and validation of a genetic algorithm for flexible docking [J].
Jones, G ;
Willett, P ;
Glen, RC ;
Leach, AR ;
Taylor, R .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 267 (03) :727-748
[8]  
Khan MTH, 2012, CURR MED CHEM, V19, P2262
[9]   Crystal structure of a plant catechol oxidase containing a dicopper center [J].
Klabunde, T ;
Eicken, C ;
Sacchettini, JC ;
Krebs, B .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (12) :1084-1090
[10]   Flavonols from Heterotheca inuloides:: Tyrosinase inhibitory activity and structural criteria [J].
Kubo, I ;
Kinst-Hori, I ;
Chaudhuri, SK ;
Kubo, Y ;
Sánchez, Y ;
Ogura, T .
BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (07) :1749-1755